Heterocyclic inhibitors of ERK2 and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S340000, C514S341000, C514S342000, C514S343000, C546S270400, C546S271100, C546S271400, C546S272100, C546S272400, C546S274100, C546S275400, C546S279100, C546S280400, C546S284700

Reexamination Certificate

active

10770814

ABSTRACT:
Described herein are compounds that are useful as protein kinase inhibitors having the formula:wherein Z1and Z2are each independently nitrogen or CH and Ring A, TmR1, QR2, UnR3, and Sp are as described in the specification. The compounds are especially useful as inhibitors of ERK2 and for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, diabetes, and cardiovascular disease.

REFERENCES:
patent: 5792778 (1998-08-01), de Laszlo et al.
patent: WO 95/13067 (1995-05-01), None
patent: WO 97/05878 (1997-02-01), None
patent: WO 97/16442 (1997-05-01), None
patent: WO 99/32121 (1999-07-01), None
patent: WO 99/58523 (1999-11-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 01/74811 (2001-10-01), None
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-6, 1996.
Rogers et al., PubMed Abstract (J Cell Biol. 157(2):219-29) Apr. 2002.
Tanaka et al., PubMed Abstract (Cell. 108(3):317-29) Feb. 2000.
Hardt et al., Glycogen Synthase Kinase -3beta: A Novel Regulator of Cardiac Hypertrophy and Development, Circulation Research, 90:1055-1063, 2002.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic inhibitors of ERK2 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic inhibitors of ERK2 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic inhibitors of ERK2 and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3892782

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.